Special Report – Veterans and HBOT
The unfortunate truth is that countless veterans, just like Simon, repeatedly battle suicidal thoughts. They struggle from their battle wounds and PTSD with each passing minute.
These brave souls protected our country, and it’s beyond time that we protect their future. Thankfully there is hope in HBOT.
Watch the 30 Minute Special Report
Veterans are at especially high risk for suicide due to the injuries they’ve endured and the horrific images they’ve seen. Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) rank high among the reasons why veterans are choosing death over living. But there is hope for new beginnings. Hyperbaric oxygen therapy (HBOT) is helping war veterans turn their lives around.
In this Special Report, Edward diGirolamo, host of the HBOT News Network, dives into HBOT and what the state of North Carolina is doing to help get veterans this life saving therapy. We hear from Melissa Spain, CEO of the Community Foundation of NC East, as she discusses their involvement to get NC Senate Bill 442 passed; a bill that has appropriated funds to provide HBOT to NC veterans who suffer from TBI and PTSD.
We are also greeted by Elena Schertz, Nurse Practitioner at Extivita-RTP in Durham, NC. Elena gives us a tour of their state-of-the-art clinic where soldiers are receiving HBOT. One of their veteran patients, Simon LeMay, agreed to share his story with us to help spread the hope that exists within the world of hyperbaric oxygen therapy.
Meet a true American Hero, Simon LeMay, retired Sergeant Major with 25-years in the US Marine Corps. LeMay was deployed to Iraq and Afghanistan five times during a ten year period. He lost his best friend in battle and witnessed horrific incidents of violence and injury among his Marine bothers. Although LeMay was blessed to avoid serious physical injury to himself, he did come home with an invisible wound of war.
IED exposures left him with a TBI and visions of war and death haunted him with PTSD. Simon turned to alcohol and pain pills to ease the emotional and physical pain, leading him down a dark tunnel of depression and suicidal thoughts that almost ended in demise.
After hearing about it from friends, his loving family talked him into trying hyperbaric oxygen therapy to help heal his brain injuries. LeMay received treatment at Extivita- RTP in Durham, NC and states after 20-30 treatments he started realizing that he was once again “starting to feel emotion,” with the sense of worthlessness disappearing and the suicidal ideation being no more.
“I started looking forward to the next day,” Simon exclaims.
Also included in this Special Report is a raw and personal interview with Cate, Simon’s wife. Today she is thrilled with Simon’s progress, even calling hyperbaric oxygen therapy “God sent.”
Subscribe Now, It’s Free!
Recent HBOT News
Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Ischemic stroke is a devastating and debilitating medical condition with limited therapeutic options. However, accumulating evidence indicates a central role of inflammation in all aspects of stroke including its initiation, the progression of injury, and recovery or wound healing. A central target of inflammation is disruption of the blood brain barrier or neurovascular unit. Here we discuss recent developments in identifying potential molecular targets and immunomodulatory approaches to preserve or protect barrier function and limit infarct damage and functional impairment.
Clinical Trial – Nalbuphine Versus Fentanyl As Additives To Bupivacaine In Spinal Anaesthesia For Internal FixationI Of Tibia
The Efficacy Of Nalbuphine Versus Fentanyl As Additives To Bupivacaine In Spinal Anaesthesia
For Internal FixationI Of Tibia
Early Effects of Hyperbaric Oxygen on Inducible Nitric Oxide Synthase Activity/Expression in Lymphocytes of Type 1 Diabetes Patients: A Prospective Pilot Study.
This study aimed at examining the early effects of hyperbaric oxygen therapy (HBOT) on inducible nitric oxide synthase (iNOS) activity/expression in lymphocytes of type 1 diabetes mellitus (T1DM) patients. A group of 19 patients (mean age: 63 ± 2.1) with T1DM and with the peripheral arterial disease were included in this study. Patients were exposed to 10 sessions of HBOT in the duration of 1 h to 100% oxygen inhalation at 2.4 ATA. Blood samples were collected for the plasma C-reactive protein (CRP), plasma free fatty acid (FFA), serum nitrite/nitrate, and serum arginase activity measurements. Expression of iNOS and phosphorylation of p65 subunit of nuclear factor-B (NFB-p65), extracellular-regulated kinases 1/2 (ERK1/2), and protein kinase B (Akt) were examined in lymphocyte lysates by Western blot.


